One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Integer Holdings Corporation logo
Integer Holdings Corporation ITGR
$ 126.97 -0.01%
report update icon

Quarterly report 2026-Q3
added 10-29-2026

Integer Holdings Corporation Balance Sheet 2025-2009 | ITGR

Brief overview of Integer Holdings Corporation's balance sheet structure

The balance sheet is assessed across five available annual reports spanning 2021 to 2025.

Over the period, assets gained +32.1%, moving from $2.6 billion to $3.4 billion. CAGR near 7.2% shows consistent growth.

Liabilities followed the scale of the balance sheet: +35.6% versus +32.1% for assets. Leverage did not change materially.

The equity ratio reached 51.2% from 52.5%. A high capital share reduces dependence on liabilities.

Net debt equals about 0.67x of equity. The burden is manageable, but further growth would warrant attention.

Cash represents 0.5% of assets versus 0.7% initially, showing how the immediate liquidity reserve changed.

By the end of the period, accumulated earnings were $994.1 million; the change from the start was +61.8%.

Conclusion

Integer Holdings Corporation's balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.

Annual Balance Sheet Integer Holdings Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Net Debt

1.18 B 941 M 945 M 893 M 805 M 653 M 801 M 900 M 1.57 B 1.63 B 110 M 162 M - 205 M 200 M 198 M -

Long Term Debt

1.19 B 980 M 960 M 907 M 813 M 694 M 777 M 888 M 1.58 B 1.69 B 175 M 198 M - 225 M 236 M 221 M -

Long Term Debt Current

9.1 M 7.35 M 8.56 M 10.4 M 9.86 M 8.43 M 7.51 M 37.5 M 30.5 M 31.3 M 11.2 M - - - - - -

Total Non Current Liabilities

1.43 B 1.23 B 1.2 B 1.15 B 1.07 B 945 M 1.02 B 1.1 B 1.75 B 1.92 B 233 M 257 M - 317 M 320 M 290 M -

Total Current Liabilities

232 M 227 M 221 M 224 M 160 M 156 M 179 M 165 M 209 M 185 M 109 M 91.8 M - 91.8 M 94 M 60.6 M -

Total Liabilities

1.66 B 1.46 B 1.42 B 1.38 B 1.23 B 1.1 B 1.2 B 1.27 B 1.95 B 2.13 B 342 M 349 M - 409 M 414 M 350 M -

Deferred Revenue

5.21 M 4.44 M 6.14 M 5.62 M 3.78 M 2.5 M 1.98 M 2.48 M 4.15 M 3.59 M 6.17 M 6.01 M - 7.68 M 7.83 M - -

Retained Earnings

994 M 891 M 771 M 681 M 614 M 518 M 440 M 344 M 176 M 232 M 239 M 184 M - 148 M 152 M 119 M -

Total Assets

3.41 B 3.08 B 2.94 B 2.79 B 2.58 B 2.37 B 2.35 B 2.33 B 2.85 B 2.98 B 955 M 891 M - 890 M 881 M 777 M -

Cash and Cash Equivalents

17.2 M 46.5 M 23.7 M 24.3 M 17.9 M 49.2 M 13.5 M 25.6 M 44.1 M 52.1 M 76.8 M 35.5 M - 20.3 M 36.5 M 22.9 M 22.1 M

Book Value

1.75 B 1.62 B 1.52 B 1.42 B 1.35 B 1.27 B 1.15 B 1.06 B 893 M 851 M 613 M 542 M - 481 M 467 M 427 M -

Total Shareholders Equity

1.75 B 1.62 B 1.52 B 1.42 B 1.35 B 1.27 B 1.15 B 1.06 B 893 M 725 M 613 M 542 M - 481 M 467 M 427 M 375 M

All numbers in USD currency

Quarterly Balance Sheet Integer Holdings Corporation

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

67.4 M 67.1 M 69.3 M 81.9 M 82.7 M 83.9 M 85.7 M 77.7 M 69.1 M 71.9 M 74.3 M 72.1 M 57.3 M 60 M 62 M 64 M 62 M 64.4 M 64.3 M 59.8 M 41.4 M 43.1 M 45.2 M 37.9 M 39 M 40.6 M 42.5 M 37.1 M 38.7 M 39.8 M 33.8 M 888 M 954 M 1.54 B 1.56 B 1.61 B 1.63 B 1.67 B 1.7 B 1.73 B 1.75 B 1.76 B 1.76 B 1.71 B 180 M 182 M 185 M 187 M 190 M 192 M 195 M 198 M 210 M 237 M 233 M 225 M 230 M 233 M 239 M 236 M 198 M 206 M 236 M

Total Non Current Liabilities

1.47 B 1.49 B 1.51 B 1.43 B 1.44 B 1.45 B 1.48 B 1.23 B 1.32 B 1.37 B 1.39 B 1.2 B 1.17 B 1.22 B 1.23 B 1.15 B 1.18 B 1.2 B 1.07 B 1.07 B 859 M 880 M 904 M 945 M 1.06 B 1.19 B 1.05 B 1.02 B 1.04 B 1.08 B 1.12 B 1.1 B 1.14 B 1.66 B 1.7 B 1.75 B 1.82 B 1.87 B 1.89 B 1.92 B 1.94 B 1.96 B 1.96 B 1.92 B 220 M 226 M 231 M 233 M 244 M 250 M 254 M 257 M 269 M 295 M 293 M 317 M 319 M 320 M 325 M 320 M 274 M 281 M -

Total Liabilities

1.67 B 1.7 B 1.71 B 1.66 B 1.65 B 1.67 B 1.69 B 1.46 B 1.55 B 1.57 B 1.59 B 1.42 B 1.38 B 1.42 B 1.46 B 1.38 B 1.38 B 1.39 B 1.24 B 1.23 B 1.02 B 1.04 B 1.07 B 1.1 B 1.22 B 1.34 B 1.23 B 1.2 B 1.23 B 1.26 B 1.29 B 1.27 B 1.32 B 1.89 B 1.93 B 1.95 B 2.03 B 2.06 B 2.1 B 2.11 B 2.14 B 2.18 B 2.18 B 2.13 B 338 M 325 M 318 M 342 M 334 M 328 M 324 M 349 M 360 M 394 M 396 M 409 M 411 M 402 M 404 M 414 M 348 M 356 M 414 M

Deferred Revenue

5.68 M 4.47 M 5.38 M 5.21 M 3.71 M 4.23 M 4.06 M 4.44 M 4.99 M 5.07 M 5.93 M 6.14 M 5.82 M 8.78 M 6.37 M 5.62 M 6.16 M 8.72 M 7.02 M 3.78 M 2.86 M 2.52 M 2.38 M 2.5 M 1.93 M 2.42 M 3.16 M 1.98 M 2.08 M 2.36 M 1.99 M 2.48 M 4.1 M 3.2 M 4.4 M 2.2 M - 2.2 M 3.6 M - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

1.05 B 1.03 B 1.01 B 994 M 945 M 906 M 869 M 891 M 859 M 823 M 792 M 771 M 745 M 718 M 694 M 681 M 663 M 647 M 626 M 614 M 591 M 568 M 539 M 518 M 502 M 472 M 471 M 440 M 429 M 399 M 366 M 344 M 318 M 204 M 184 M 176 M 122 M 108 M 105 M 109 M 101 M 89.7 M 90.5 M 232 M 257 M 257 M 247 M 239 M 225 M 211 M 199 M 184 M 174 M 163 M 153 M 148 M 153 M 161 M 157 M 153 M 147 M 140 M 153 M

Total Assets

3.39 B 3.42 B 3.41 B 3.41 B 3.4 B 3.37 B 3.3 B 3.08 B 3.17 B 3.13 B 3.12 B 2.94 B 2.84 B 2.86 B 2.87 B 2.79 B 2.74 B 2.76 B 2.61 B 2.58 B 2.35 B 2.36 B 2.34 B 2.37 B 2.45 B 2.52 B 2.4 B 2.35 B 2.36 B 2.37 B 2.37 B 2.33 B 2.36 B 2.81 B 2.85 B 2.85 B 2.85 B 2.84 B 2.84 B 2.83 B 2.88 B 2.9 B 2.91 B 2.98 B 984 M 966 M 947 M 955 M 931 M 912 M 890 M 890 M 885 M 897 M 885 M 890 M 892 M 886 M 887 M 881 M 812 M 820 M 881 M

Cash and Cash Equivalents

14.1 M 21.4 M 8.12 M 17.2 M 58.9 M 23.1 M 31.7 M 46.5 M 35.6 M 34.1 M 42.2 M 23.7 M 32.1 M 38.6 M 40.6 M 24.3 M 20.2 M 15.6 M 25.7 M 17.9 M 25.5 M 30.6 M 28.4 M 49.2 M 99.9 M 206 M 37.3 M 13.5 M 14.7 M 15.9 M 13.5 M 25.6 M 22.9 M 18.9 M 29.5 M 44.1 M 43.6 M 41 M 54.9 M 52.1 M 45 M 36.6 M 54.1 M 82.5 M 68.6 M 72.3 M 67 M 76.8 M 61.6 M 51.2 M 38.3 M 35.5 M 4.97 M 10.2 M 10.1 M 20.3 M 10.8 M 11.1 M 9.53 M 36.5 M 41.6 M 36.9 M 36.5 M

Book Value

1.73 B 1.72 B 1.7 B 1.75 B 1.75 B 1.7 B 1.61 B 1.62 B 1.62 B 1.55 B 1.53 B 1.52 B 1.46 B 1.45 B 1.42 B 1.42 B 1.36 B 1.36 B 1.36 B 1.35 B 1.33 B 1.31 B 1.28 B 1.27 B 1.23 B 1.18 B 1.16 B 1.15 B 1.13 B 1.11 B 1.08 B 1.06 B 1.04 B 918 M 920 M 893 M 823 M 783 M 741 M 725 M 741 M 723 M 732 M 851 M 646 M 642 M 628 M 613 M 597 M 583 M 567 M 541 M 524 M 503 M 489 M 481 M 481 M 484 M 483 M 467 M 464 M 464 M 467 M

Total Shareholders Equity

1.73 B 1.72 B 1.7 B 1.75 B 1.75 B 1.7 B 1.61 B 1.62 B 1.62 B 1.55 B 1.53 B 1.52 B 1.46 B 1.45 B 1.42 B 1.42 B 1.36 B 1.36 B 1.36 B 1.35 B 1.33 B 1.31 B 1.28 B 1.27 B 1.23 B 1.18 B 1.16 B 1.15 B 1.13 B 1.11 B 1.08 B 1.06 B 1.04 B 918 M 920 M 893 M 823 M 783 M 741 M 725 M 741 M 723 M 732 M 851 M 646 M 642 M 628 M 613 M 597 M 583 M 567 M 542 M 524 M 503 M 489 M 481 M 481 M 484 M 483 M 467 M 464 M 464 M 467 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Integer Holdings Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Abbott Laboratories Abbott Laboratories
ABT
$ 103.08 -0.98 % $ 179 B usaUSA
Align Technology Align Technology
ALGN
$ 154.77 -3.07 % $ 11.2 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 6.66 -3.48 % $ 999 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 41.95 -2.43 % $ 62.1 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
Butterfly Network Butterfly Network
BFLY
$ 5.39 -8.28 % $ 1.33 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 358.56 -2.43 % $ 9.78 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 101.86 -1.94 % $ 59.6 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 5.49 13.33 % $ 3.7 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.39 2.06 % $ 98.2 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 7.27 -6.56 % $ 530 M israelIsrael
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 99.64 -1.0 % $ 128 B usaUSA
Myomo Myomo
MYO
$ 0.81 -3.74 % $ 33.9 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 69.2 -0.59 % $ 2.05 B costa-ricaCosta-rica
Insulet Corporation Insulet Corporation
PODD
$ 133.09 -3.02 % $ 9.36 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.39 -3.03 % $ 193 M canadaCanada
Delcath Systems Delcath Systems
DCTH
$ 18.77 -2.44 % $ 672 M usaUSA
Electromed Electromed
ELMD
$ 23.03 -1.46 % $ 190 M usaUSA
Inogen Inogen
INGN
$ 5.3 -2.31 % $ 141 M usaUSA
Globus Medical Globus Medical
GMED
$ 66.85 -2.55 % $ 9.04 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 1.13 -4.24 % $ 3.13 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 81.04 -0.25 % $ 1.03 B usaUSA
Penumbra Penumbra
PEN
$ 319.13 -0.27 % $ 12.4 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 29.85 0.05 % $ 25.9 B britainBritain
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 6.91 -5.47 % $ 196 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 2.28 -3.39 % $ 37.2 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 2.1 -1.18 % $ 258 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 309.41 -1.24 % $ 118 B usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
AxoGen AxoGen
AXGN
$ 55.74 -1.08 % $ 2.57 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 25.62 -1.42 % $ 586 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 1.95 -3.94 % $ 83.1 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.69 -4.9 % $ 32.4 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.45 -4.57 % $ 7.62 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.37 -14.76 % $ 272 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 85.17 -9.42 % $ 2.9 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.25 -2.21 % $ 1.02 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.23 -2.13 % $ 14.9 M israelIsrael